Edition:
United Kingdom

Epizyme Inc (EPZM.OQ)

EPZM.OQ on NASDAQ Stock Exchange Global Select Market

7.15USD
2:58pm GMT
Change (% chg)

$-0.08 (-1.11%)
Prev Close
$7.23
Open
$7.29
Day's High
$7.29
Day's Low
$6.90
Volume
16,979
Avg. Vol
144,244
52-wk High
$21.35
52-wk Low
$6.90

Chart for

About

Epizyme, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops and plans to commercialize epigenetic therapies for cancer patients. The Company is engaged in the discovery and development of novel epigenetic therapies for cancer patients. The Company develops small molecule inhibitors of a class of... (more)

Overall

Beta: 2.21
Market Cap(Mil.): $1,257.42
Shares Outstanding(Mil.): 67.79
Dividend: --
Yield (%): --

Financials

  EPZM.OQ Industry Sector
P/E (TTM): -- 83.62 33.60
EPS (TTM): -2.06 -- --
ROI: -51.70 -0.65 15.05
ROE: -59.18 0.07 16.62

CORRECTED-BRIEF-Epizyme Reports Q3 Loss of $0.54 Per Share

* EPIZYME REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS AND TAZEMETOSTAT PROGRESS

02 Nov 2018

Earnings vs. Estimates